SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss

SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss

Abstract Background Sarcopenia and osteoporosis frequently co‐occur in the elderly and have common pathophysiological determinants. Slit guidance ligand 3 (SLIT3) has been recently discovered as a novel therapeutic factor against osteoporosis, and a SLIT3 fragment containing the second leucine‐rich...

Full description

Bibliographic Details
Main Authors: Han Jin Cho, Hyeonmok Kim, Young‐Sun Lee, Sung Ah Moon, Jin‐Man Kim, Hanjun Kim, Min Ji Kim, Jiyoung Yu, Kyunggon Kim, In‐Jeoung Baek, Seung Hun Lee, Kyong Hoon Ahn, Sungsub Kim, Jong‐Sun Kang, Jung‐Min Koh
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Journal of Cachexia, Sarcopenia and Muscle
Subjects:
Slit3
Robo2
LRRD2
Muscle loss
Online Access:https://doi.org/10.1002/jcsm.12769

Internet

https://doi.org/10.1002/jcsm.12769

Similar Items